Requirement of type III TGF-β receptor for endocardial cell transformation in the heart

Christopher B. Brown; Angelique S. Boyer; Raymond B. Runyan; Joey V. Barnett

doi:10.1126/science.283.5410.2080

Requirement of type III TGF-β receptor for endocardial cell transformation in the heart

Christopher B. Brown, Angelique S. Boyer, Raymond B. Runyan, Joey V. Barnett

Cellular and Molecular Medicine

Research output: Contribution to journal › Article › peer-review

335 Scopus citations

Abstract

Transforming growth factor-β (TGF-β) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no dearly defined role in TGF-β signaling. Cardiac endothelial cells that undergo epithelial- mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial ceils conferred transformation in response to TGF-β2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-β signaling.

Original language	English (US)
Pages (from-to)	2080-2082
Number of pages	3
Journal	Science
Volume	283
Issue number	5410
DOIs	https://doi.org/10.1126/science.283.5410.2080
State	Published - Mar 26 1999

ASJC Scopus subject areas

General

Access to Document

10.1126/science.283.5410.2080

Cite this

@article{5d88af12723e4b1fa41303375cc1af59,

title = "Requirement of type III TGF-β receptor for endocardial cell transformation in the heart",

abstract = "Transforming growth factor-β (TGF-β) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no dearly defined role in TGF-β signaling. Cardiac endothelial cells that undergo epithelial- mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial ceils conferred transformation in response to TGF-β2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-β signaling.",

author = "Brown, {Christopher B.} and Boyer, {Angelique S.} and Runyan, {Raymond B.} and Barnett, {Joey V.}",

year = "1999",

month = mar,

day = "26",

doi = "10.1126/science.283.5410.2080",

language = "English (US)",

volume = "283",

pages = "2080--2082",

journal = "Science",

issn = "0036-8075",

publisher = "American Association for the Advancement of Science",

number = "5410",

}

TY - JOUR

T1 - Requirement of type III TGF-β receptor for endocardial cell transformation in the heart

AU - Brown, Christopher B.

AU - Boyer, Angelique S.

AU - Runyan, Raymond B.

AU - Barnett, Joey V.

PY - 1999/3/26

Y1 - 1999/3/26

N2 - Transforming growth factor-β (TGF-β) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no dearly defined role in TGF-β signaling. Cardiac endothelial cells that undergo epithelial- mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial ceils conferred transformation in response to TGF-β2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-β signaling.

AB - Transforming growth factor-β (TGF-β) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no dearly defined role in TGF-β signaling. Cardiac endothelial cells that undergo epithelial- mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial ceils conferred transformation in response to TGF-β2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-β signaling.

UR - http://www.scopus.com/inward/record.url?scp=0033605704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033605704&partnerID=8YFLogxK

U2 - 10.1126/science.283.5410.2080

DO - 10.1126/science.283.5410.2080

M3 - Article

C2 - 10092230

AN - SCOPUS:0033605704

SN - 0036-8075

VL - 283

SP - 2080

EP - 2082

JO - Science

JF - Science

IS - 5410

ER -

Requirement of type III TGF-β receptor for endocardial cell transformation in the heart

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this